Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review

被引:442
|
作者
Boonstra, Kirsten [1 ]
Beuers, Ulrich [1 ]
Ponsioen, Cyriel Y. [1 ]
机构
[1] Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1100 DD Amsterdam, Netherlands
关键词
Primary sclerosing cholangitis; Primary biliary cirrhosis; Epidemiology; Incidence; Prevalence; POPULATION-BASED COHORT; URSODEOXYCHOLIC ACID; NATURAL-HISTORY; DEFINED POPULATION; CLINICAL-FEATURES; PREVALENCE; COMMUNITY; SWEDEN; CHOLANGIOGRAPHY; AUSTRALIA;
D O I
10.1016/j.jhep.2011.10.025
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: Studies on the epidemiology of primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC) show variable outcome. We aimed at systematically reviewing the incidence and prevalence rates, as well as geographical distribution and temporal trends of PSC and PBC. Data sources: A systematic search of literature was performed in Medline and EMBASE (search last conducted January 10th, 2011). Study selection: Population-based epidemiological studies reporting incidence and/or prevalence rates for PSC or PBC in a defined geographical area of at least 100,000 adult inhabitants were considered relevant. Data extraction: Study area, study period, number of patients, number of inhabitants, incidence per 100,000 inhabitants per year, prevalence per 100,000 inhabitants, method of case-finding, method of case-ascertainment, male/female ratio and in case of PSC, occurrence of inflammatory bowel diseases (IBD) were extracted from retrieved articles. Results: The literature search yielded 2286 abstracts of which 31 articles fulfilled all inclusion criteria. Studies varied in size from 10 to 770 patients in catchment areas from 100,312 to 19,230,000 inhabitants. The incidence and prevalence rates for PSC range from 0 to 1.3 per 100,000 inhabitants/year and 0-16.2 per 100,000 inhabitants, respectively. PBC incidence rates range from 0.33 to 5.8 per 100,000 inhabitants/year and prevalence rates range from 1.91 to 40.2 per 100,000 inhabitants; prevalence rates are increasing in time. Conclusions: Incidence and prevalence rates of both PSC and PBC vary widely and seem to be increasing. True population-based studies are scarce and therefore large population-based studies combining meticulous case-finding and case-ascertainment strategies are necessary. (C) 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1181 / 1188
页数:8
相关论文
共 50 条
  • [41] Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health Perspective
    Beery, Renee M. Marchioni
    Vaziri, Haleh
    Forouhar, Faripour
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2014, 2 (04) : 266 - 284
  • [42] The Immunophysiology and Apoptosis of Biliary Epithelial Cells: Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
    Kazuhito Kawata
    Yoshimasa Kobayashi
    M. Eric Gershwin
    Christopher L. Bowlus
    Clinical Reviews in Allergy & Immunology, 2012, 43 : 230 - 241
  • [43] Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis.
    Franco J.
    Saeian K.
    Current Gastroenterology Reports, 1999, 1 (2) : 95 - 101
  • [44] The Immunophysiology and Apoptosis of Biliary Epithelial Cells: Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
    Kawata, Kazuhito
    Kobayashi, Yoshimasa
    Gershwin, M. Eric
    Bowlus, Christopher L.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2012, 43 (03) : 230 - 241
  • [45] Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
    Cheung, Angela C.
    LaRusso, Nicholas F.
    Gores, Gregory J.
    Lazaridis, Konstantinos N.
    SEMINARS IN LIVER DISEASE, 2017, 37 (02) : 159 - 174
  • [46] Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography
    BenAri, Z
    Panagou, M
    Patch, D
    Bates, S
    Osman, E
    Pasi, J
    Burroughs, A
    JOURNAL OF HEPATOLOGY, 1997, 26 (03) : 554 - 559
  • [47] Recurrence of primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation
    Neuberger, J
    CHOLESTATIC LIVER DISEASES IN CHILDREN AND ADULTS, 1996, 89B : 98 - 107
  • [48] Ursodeoxycholic acid in the treatment of primary biliary cirrhosis and primary sclerosing cholangitis in pregnancy
    Holtmeier, J
    Leuschner, M
    Stiehl, A
    Klein, R
    Leuschner, U
    BILE ACIDS AND PREGNANCY, 2002, 129A : 70 - 74
  • [49] AUTOREACTIVITY TO HEPATOCELLULAR ANTIGENS IN PRIMARY BILIARY-CIRRHOSIS AND PRIMARY SCLEROSING CHOLANGITIS
    BEDLOW, AJ
    DONALDSON, PT
    MCFARLANE, BM
    LOMBARD, M
    MCFARLANE, IG
    WILLIAMS, R
    JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY, 1989, 30 (03) : 103 - 109
  • [50] COMPARISON OF THE CLINICOPATHOLOGIC FEATURES OF PRIMARY SCLEROSING CHOLANGITIS AND PRIMARY BILIARY-CIRRHOSIS
    WIESNER, RH
    LARUSSO, NF
    LUDWIG, J
    DICKSON, ER
    GASTROENTEROLOGY, 1985, 88 (01) : 108 - 114